Retationship between atrial tachyarrhythmias and symptoms

被引:150
作者
Strickberger, SA
Ip, J
Saksena, S
Curry, K
Bahnson, TD
Ziegler, PD
机构
[1] Washington Hosp Ctr, Div Cardiol, Washington, DC 20010 USA
[2] Ingham Reg Med Ctr, Lansing, MI USA
[3] Gen Hosp Passaic, Passaic, NJ USA
[4] Mem Hosp, Colorado Springs, CO USA
[5] Duke Univ, Ctr Med, Durham, NC USA
[6] Medtronic Inc, Minneapolis, MN USA
关键词
atrial fibrillation; pacing; bradycardia;
D O I
10.1016/j.hrthm.2004.10.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this study was to correlate patient-reported symptoms of atrial fibrillation with the underlying rhythm. BACKGROUND The reliability of patient-reported symptoms as a marker of atrial fibrillation recurrence has not been well studied. METHODS This prospective multicenter trial correlated the recurrence of atrial tachyarrhythmias with symptoms in patients with a history of atrial fibrillation and a standard indication for permanent pacing. Pacemaker-detected atrial tachyarrhythmia events were correlated with symptoms. Patients logged symptomatic events into the device's memory via an external manual activator. Patients were followed for 12 months and were contacted weekly to ensure compliance with activator usage. Episodes were classified as symptomatic atrial tachyarrhythmia, asymptomatic atrial tachyarrhythmia, or symptomatic nonatrial tachyarrhythmia depending on concordance between patient symptoms and the rhythm. RESULTS Forty-eight patients underwent implantation of a DDDRP pacemaker and were followed for 12 +/- 2 months. A median of 25.0 (4.0-55.8) symptomatic events attributed to atrial fibrillation. A median of 1.0 (0.0-10.0) symptomatic atrial tachyarrhythmia episodes were documented during follow-up. Symptoms related to atrial fibrillation were reported in 6% of atrial tachyarrhythmia episodes identified by the pacemaker. The probability that symptoms were associated with an atrial tachyarrhythmia (positive predictive value) was 17%. The ventricular rate between symptomatic and asymptomatic atrial tachyarrhythmia events was not significantly different. CONCLUSIONS Among patients with symptomatic bradycardia and a history of atrial fibrillation, symptoms of atrial fibrillation often were not associated with documented atrial tachyarrhythmias, and more than 90% of atrial tachyarrhythmias were clinically silent.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 11 条
  • [1] CORRELATION OF SYMPTOMS WITH OCCURRENCE OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA OR ATRIAL-FIBRILLATION - A TRANSTELEPHONIC MONITORING STUDY
    BHANDARI, AK
    ANDERSON, JL
    GILBERT, EM
    ALPERT, BL
    HENTHORN, RW
    WALDO, AL
    CULLEN, MT
    HAWKINSON, RW
    PRITCHETT, ELC
    [J]. AMERICAN HEART JOURNAL, 1992, 124 (02) : 381 - 386
  • [2] Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study
    Defaye, P
    Dournaux, F
    Mouton, E
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (01): : 250 - 255
  • [3] ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices - Summary article - A report of the American College of Cardiology American Heart Association task force on practice guidelines - (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)
    Gregoratos, G
    Abrams, J
    Epstein, AE
    Freedman, RA
    Hayes, DL
    Hlatky, MA
    Kerber, RE
    Naccarelli, GV
    Schoenfeld, MH
    Silka, MJ
    Winters, SL
    Gibbons, RJ
    Antman, EM
    Alpert, JS
    Gregoratos, G
    Hiratzka, LF
    Faxon, DP
    Jacobs, AK
    Fuster, V
    Smith, SC
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (09) : 1703 - 1719
  • [4] Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation:: Insights from a study using a new implantable device
    Israel, CW
    Ehrlich, JR
    Grönefeld, G
    Klesius, A
    Lawo, T
    Lemke, B
    Hohnloser, SH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) : 355 - 363
  • [5] Pace-termination and pacing for prevention of atrial tachyarrhythmias:: Results from a multicenter study with an implantable device for atrial therapy
    Israel, CW
    Hügl, B
    Unterberg, C
    Lawo, T
    Kennis, I
    Hettrick, D
    Hohnloser, SH
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2001, 12 (10) : 1121 - 1128
  • [6] Long-term risk of recurrent atrial fibrillation as documented by an Implantable monitoring device -: Implications for optimal patient care
    Israel, CW
    Grönefeld, G
    Ehrlich, JR
    Li, YG
    Hohnloser, SH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) : 47 - 52
  • [7] Asymptomatic or "silent" atrial fibrillation - Frequency in untreated patients and patients receiving azimilide
    Page, RL
    Tilsch, TW
    Connolly, SJ
    Schnell, DJ
    Marcello, SR
    Wilkinson, WE
    Pritchett, ELC
    [J]. CIRCULATION, 2003, 107 (08) : 1141 - 1145
  • [8] ASYMPTOMATIC ARRHYTHMIAS IN PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL-FIBRILLATION AND PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
    PAGE, RL
    WILKINSON, WE
    CLAIR, WK
    MCCARTHY, EA
    PRITCHETT, ELC
    [J]. CIRCULATION, 1994, 89 (01) : 224 - 227
  • [9] Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion
    Tse, HF
    Lau, CP
    Ayers, GM
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (14) : 1167 - 1176
  • [10] Wilkoff BL, 2001, CIRCULATION, V103, P381